GSI 705 (Truvada 167 mg / 250 mg)
Generic Name: emtricitabine/tenofovir
Pill with imprint GSI 705 is Blue, Capsule-shape and has been identified as Truvada 167 mg / 250 mg. It is supplied by Gilead Sciences, Inc..
Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 167 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 705
Truvada
- Generic Name:
- emtricitabine/tenofovir
- Imprint:
- GSI 705
- Strength:
- 167 mg / 250 mg
- Color:
- Blue
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Gilead Sciences, Inc.
- National Drug Code (NDC):
- 61958-0705
More about Truvada (emtricitabine / tenofovir)
- Truvada Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 16 Reviews
- Generic Availability
- Drug class: antiviral combinations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
